1. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. Issue 10333 (9th April 2022) Authors: Piccini, Jonathan P; Caso, Valeria; Connolly, Stuart J; Fox, Keith A A; Oldgren, Jonas; Jones, W Schuyler; Gorog, Diana A; Durdil, Václav; Viethen, Thomas; Neumann, Christoph; Mundl, Hardi; Patel, Manesh R; Auer, Johann; Hubauer, Martin; Pandzic, Sead; Preishuber, Eva; Primus-Grabscheit, Carina; ... Journal: Lancet Issue: Volume 399:Issue 10333(2022) Page Start: 1383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Supraventricular tachyarrhythmias that responded dramatically to bisoprolol transdermal patches in two patients undergoing hemodialysis. Issue 6 (13th June 2019) Authors: Matsumoto, Takahiro; Tamiya, Eiji; Yamamoto, Shouichi; Kamiyama, Takashi; Takabe, Tomosato; Kanoh, Tatsuji; Daida, Hiroyuki Journal: Annals of noninvasive electrocardiology Issue: Volume 24:Issue 6(2019:Nov.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗